Kwon, J., Kim, K., Sung, J. H., Suh, K. J., Lee, J. Y., Kim, J., . . . Lee, J. S. (2019). Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement. Cells.
Παραπομπή Chicago StyleKwon, Ji-Hyun, et al. "Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement." Cells 2019.
Παραπομπή MLAKwon, Ji-Hyun, et al. "Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement." Cells 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.